Quick Takeaways
- PRICE T ROWE ASSOCIATES INC /MD/ filed SCHEDULE 13G/A for PLIANT THERAPEUTICS INC COMMON STOCK (PLRX).
- Disclosed ownership: 0.1%.
- Date of event: 31 Mar 2025.
PRICE T ROWE ASSOCIATES INC /MD/ - 31 Mar 2025 SCHEDULE 13G/A Report for PLIANT THERAPEUTICS INC COMMON STOCK (PLRX)
- Filing Manager
- PRICE T ROWE ASSOCIATES INC /MD/
- Reporting Manager
- T. Rowe Price Associates, Inc.
- Security
- PLIANT THERAPEUTICS INC COMMON STOCK
- Symbol
- PLRX
- Disclosed Ownership
- 87,674 shares
- Ownership
- 0.1%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 May 2025, 10:45:26 UTC
- Date of event
- 31 Mar 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"PRICE T ROWE ASSOCIATES INC /MD/ disclosed 0.1% ownership in PLIANT THERAPEUTICS INC COMMON STOCK (PLRX) on 31 Mar 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 May 2025, 10:45.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| T. Rowe Price Associates, Inc. | 0.1% | 87,674 | 81,601 | 0 | Ellen York | Vice President |